Cargando…

Serum mucin 3A as a potential biomarker for extrahepatic cholangiocarcinoma

BACKGROUND/AIMS: The aim of this study is to evaluate serum mucin 3A (MUC3A) as a candidate biomarker for extrahepatic cholangiocarcinoma (EHCC). PATIENTS AND METHODS: 35 Patients with EHCC, 30 patients with pancreatic cancer, 35 patients with gallbladder carcinoma and 78 patients with benign biliar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jing, Zhou, Haibin, Wang, Yucheng, Huang, Haitao, Yang, Jing, Gu, Weigang, Zhang, Xiaofeng, Yang, Jianfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392288/ https://www.ncbi.nlm.nih.gov/pubmed/32270773 http://dx.doi.org/10.4103/sjg.SJG_447_19

Ejemplares similares

Novel insights into the intraepithelial spread of extrahepatic cholangiocarcinoma: clinicopathological study of 382 cases on extrahepatic cholangiocarcinoma
por: Nagashima, Daisuke, et al.
Publicado: (2023)

Recurrent extrahepatic cholangiocarcinoma after bile duct resection for intraductal papillary mucinous neoplasm of the bile duct
por: Patel, Arpan, et al.
Publicado: (2019)

An overview of extrahepatic cholangiocarcinoma: from here to where?
por: Yang, Yongheng, et al.
Publicado: (2023)

Establishment and validation of a prognostic nomogram for extrahepatic cholangiocarcinoma
por: Zhao, Fangrui, et al.
Publicado: (2022)

The Significance of Adjuvant Therapy for Extrahepatic Cholangiocarcinoma After Surgery
por: Wang, Gaoyuan, et al.
Publicado: (2019)

Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma
por: Xiao, Jing-Bo, et al.
Publicado: (2020)

MRI-based automatic identification and segmentation of extrahepatic cholangiocarcinoma using deep learning network
por: Yang, Chunmei, et al.
Publicado: (2023)

Albumin-Bilirubin Grade as a Novel Predictor of Survival in Advanced Extrahepatic Cholangiocarcinoma
por: Wang, Yong, et al.
Publicado: (2018)

Role of Endoscopic Ultrasonography in the Evaluation of Extrahepatic Cholangiocarcinoma
por: Strongin, Anna, et al.
Publicado: (2013)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma
por: Saab, Massa, et al.
Publicado: (2021)

Single-cell landscape of immunocytes in patients with extrahepatic cholangiocarcinoma
por: Xu, Lei, et al.
Publicado: (2022)

Extrahepatic Mucinous Biliary Cystadenoma: A Case Report
por: Bakhurji, Bandar R, et al.
Publicado: (2020)

Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma
por: Xu, Shu, et al.
Publicado: (2020)

Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma
por: Jung, Pyung, et al.
Publicado: (2019)

Laparoscopic hepatopancreatoduodenectomy for synchronous intrahepatic and extrahepatic cholangiocarcinoma: A case report
por: Wu, Bo, et al.
Publicado: (2023)

Extrahepatic cholangiocarcinoma with prolonged survival: a case report
por: Al-Zahir, Mohammed Z., et al.
Publicado: (2017)

Geographic Variation of Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, and Hepatocellular Carcinoma in the United States
por: Altekruse, Sean F., et al.
Publicado: (2015)

Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma
por: Nakamoto, Shuji, et al.
Publicado: (2018)

Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma
por: Chen, Zhiqiang, et al.
Publicado: (2017)

An inguinal hernia sac tumor of extrahepatic cholangiocarcinoma origin
por: Yokoyama, Naoyuki, et al.
Publicado: (2006)

Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma
por: Nordenstedt, H, et al.
Publicado: (2012)

Impact of radiotherapy in the management of locally advanced extrahepatic cholangiocarcinoma
por: Moureau-Zabotto, Laurence, et al.
Publicado: (2013)

Quantitative proteomic analysis of bile in extrahepatic cholangiocarcinoma patients
por: Son, Kuk Hui, et al.
Publicado: (2020)

Photodynamic therapy of extrahepatic cholangiocarcinoma using digital cholangioscopy
por: BRUNALDI, Vítor Ottoboni, et al.
Publicado: (2020)

Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases
por: De, Brian, et al.
Publicado: (2023)

Prognostic and clinicopathological significance of Hapto and Gremlin1 expression in extrahepatic cholangiocarcinoma
por: Wu, Zhengchun, et al.
Publicado: (2020)

BIRC7 and STC2 Expression Are Associated With Tumorigenesis and Poor Outcome in Extrahepatic Cholangiocarcinoma
por: Li, Jiequn, et al.
Publicado: (2020)

Durable response to the combination of pembrolizumab and nab-paclitaxel in a metastatic extrahepatic cholangiocarcinoma: A case report and literature review
por: Tan, Sirui, et al.
Publicado: (2022)

ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma
por: Park, Kyun Woo, et al.
Publicado: (2013)

MSI2 knockdown represses extrahepatic cholangiocarcinoma growth and invasion by inhibiting epithelial–mesenchymal transition
por: Hu, Feihu, et al.
Publicado: (2018)

The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma
por: Zhang, Ke-jun, et al.
Publicado: (2010)

Mucinous cholangiocarcinoma: Clinicopathological features of the rarest type of cholangiocarcinoma
por: Sumiyoshi, Tatsuaki, et al.
Publicado: (2017)

Clinical features and survival outcome of locally advanced extrahepatic cholangiocarcinoma
por: Lee, Sang-Jae, et al.
Publicado: (2014)

Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma
por: Kitano, Yuki, et al.
Publicado: (2018)

Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures
por: Rizzo, Alessandro, et al.
Publicado: (2020)

Extrahepatic cholangiocarcinoma: Current status of endoscopic approach and additional therapies
por: Tantau, Alina Ioana, et al.
Publicado: (2021)

Endoscopic intraductal radiofrequency ablation for extrahepatic cholangiocarcinoma: An update (2023)
por: Inoue, Tadahisa, et al.
Publicado: (2023)

Immune checkpoint inhibitor‐related molecular markers predict prognosis in extrahepatic cholangiocarcinoma
por: Jin, Bao, et al.
Publicado: (2023)

Prognostic and Clinicopathological Significance of EphB3 and Dysadherin Expression in Extrahepatic Cholangiocarcinoma
por: Wu, Zhengchun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1silr4l7bnmkkoachjrqi8buhq